Cargando…
Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines
Autores principales: | den Heijer, Jonas M., Heuberger, Jules A. A. C., Hijma, Hemme, Kruithof, Annelieke C., van Smeden, Jeroen, Groeneveld, Geert Jan, Burggraaf, Jacobus, Cohen, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292589/ https://www.ncbi.nlm.nih.gov/pubmed/33939192 http://dx.doi.org/10.1111/bcp.14843 |
Ejemplares similares
-
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective Na(V)1.8 Inhibitor, in Healthy Male Adults
por: Hijma, Hemme J, et al.
Publicado: (2021) -
A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Na(v)1.8 inhibitor, in healthy adults
por: Hijma, Hemme J., et al.
Publicado: (2021) -
A crossover study evaluating the sex‐dependent and sensitizing effects of sleep deprivation using a nociceptive test battery in healthy subjects
por: Hijma, Hemme, et al.
Publicado: (2022) -
Students’ guide to documentation in clinical trials
por: Heck, Johannes, et al.
Publicado: (2022) -
Are Good Intentions Good Enough?: Informed Consent Without Trained Interpreters
por: Hunt, Linda M., et al.
Publicado: (2007)